Health Sciences

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent.

Karen Kreeger

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Lee-Ann Donegan



In the News


6ABC.com

Bird flu suspected in deaths of 200 snow geese in Pennsylvania’s Lehigh Valley

Stephen Cole of the School of Veterinary Medicine says that indoor cats are contracting bird flu through raw pet foods of poultry origin or raw milk products.

FULL STORY →



NPR

Tuberculosis rates plunge when families living in poverty get a monthly cash payout

Aaron Richterman of the Perelman School of Medicine says that there are large and underappreciated benefits of cash-transfer programs, such as potentially ending a tuberculosis epidemic.

FULL STORY →



Self

The surgeon general calls for new warning labels on alcohol—here’s the truth about how it impacts your health

Henry Kranzler of the Perelman School of Medicine says that alcohol’s effects on the brain are observed more readily because it’s the organ of behavior.

FULL STORY →



Newsweek

Cancer breakthrough as ‘speckles’ may reveal best treatment

A paper co-authored by PIK Professor Shelley Berger finds that patterns of “speckles” in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to treatment options.

FULL STORY →



Time

Scientists are racing to develop a new bird flu vaccine

Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.

FULL STORY →